UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distal mean nocturnal baseline impedance on pH‐impedance monitoring predicts reflux burden and symptomatic outcome in gastro‐oesophageal reflux disease

Alimentary pharmacology & therapeutics, 2016-10, Vol.44 (8), p.890-898

2016

Volltextzugriff (PDF)

Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2016-08, Vol.44 (3), p.246-258

2016

Volltextzugriff (PDF)

Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH‐impedance monitoring

Neurogastroenterology and motility, 2016-09, Vol.28 (9), p.1382-1390

2016

Volltextzugriff (PDF)

Editorial: Tong‐Xie‐Yao‐Fang (TXYF) for irritable bowel syndrome with diarrhoea (IBS‐D)—ancient medicine meets modern study

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.485-486

2018

Volltextzugriff (PDF)

Upper esophageal sphincter (UES) metrics on high‐resolution manometry (HRM) differentiate achalasia subtypes

Neurogastroenterology and motility, 2017-12, Vol.29 (12), p.n/a

2017

Volltextzugriff (PDF)

The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders

Neurogastroenterology and motility, 2014-09, Vol.26 (9), p.1323-1332

2014

Volltextzugriff (PDF)

Multiple rapid swallow responses segregate achalasia subtypes on high-resolution manometry

Neurogastroenterology and motility, 2012-12, Vol.24 (12), p.1069-e561

2012

Volltextzugriff (PDF)

GERD phenotypes from pH‐impedance monitoring predict symptomatic outcomes on prospective evaluation

Neurogastroenterology and motility, 2016-04, Vol.28 (4), p.513-521

2016

Volltextzugriff (PDF)

The impact of abuse and mood on bowel symptoms and health‐related quality of life in irritable bowel syndrome (IBS)

Neurogastroenterology and motility, 2016-10, Vol.28 (10), p.1508-1517

2016

Volltextzugriff (PDF)

Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (9), p.1080-1087

2012

Volltextzugriff (PDF)

Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (6), p.784-791

2018

Volltextzugriff (PDF)

Genetic risk factors for perception of symptoms in GERD: an observational cohort study

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (2), p.289-297

2018

Volltextzugriff (PDF)

Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (10), p.1275-1291

2010

Volltextzugriff (PDF)

The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome

Journal of cellular and molecular medicine, 2021-08, Vol.25 (16), p.8047-8061

2021

Volltextzugriff (PDF)

A meta‐analysis of immunogenetic Case–Control Association Studies in irritable bowel syndrome

Neurogastroenterology and motility, 2015-05, Vol.27 (5), p.717-727

2015

Volltextzugriff (PDF)

Genetic variation in the beta‐2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health‐related quality of life

Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (3), p.313-323

2013

Volltextzugriff (PDF)

Cameron lesions in patients with hiatal hernias: prevalence, presentation, and treatment outcome

Diseases of the esophagus, 2015-07, Vol.28 (5), p.448-452

2015

Volltextzugriff (PDF)

Colonoscopy Following COVID-19 Delays in Procedures: Risk Stratification for Procedures Is Critical

Gastro hep advances, 2022, Vol.1 (4), p.546-548

2022

Volltextzugriff (PDF)

Tegaserod: What’s Old Is New Again

Clinical gastroenterology and hepatology, 2022-10, Vol.20 (10), p.2175-2184.e19

2022

Volltextzugriff (PDF)

Changes in symptom reflux association using dynamic pH thresholds during ambulatory pH monitoring: an observational cross‐sectional study

Diseases of the esophagus, 2016-11, Vol.29 (8), p.1013-1019

2016

Volltextzugriff (PDF)

Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (9), p.1192-1202

2010

Volltextzugriff (PDF)

Nontransplantation of Livers from Deceased Donors Who Are Able to Donate Another Solid Organ: How Often and Why It Happens

American journal of transplantation, 2007-01, Vol.7 (1), p.151-160

2007

Volltextzugriff (PDF)

miRNA-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in Irritable Bowel Syndrome (IBS)

NEUROGASTROENTEROLOGY AND MOTILITY, 2017, Vol.29, p.51

2017

Volltextzugriff (PDF)

Irritable Bowel Syndrome: Modern Concepts and Management Options

The American journal of medicine, 2015-08, Vol.128 (8), p.817-827

2015

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(46)
Tagungsberichte
(5)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Distal mean nocturnal baseline impedance on pH‐impedance monitoring predicts reflux burden and symptomatic outcome in gastro‐oesophageal reflux disease

Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome

Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH‐impedance monitoring

Editorial: Tong‐Xie‐Yao‐Fang (TXYF) for irritable bowel syndrome with diarrhoea (IBS‐D)—ancient medicine meets modern study

Upper esophageal sphincter (UES) metrics on high‐resolution manometry (HRM) differentiate achalasia subtypes

The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders

Multiple rapid swallow responses segregate achalasia subtypes on high-resolution manometry

GERD phenotypes from pH‐impedance monitoring predict symptomatic outcomes on prospective evaluation

The impact of abuse and mood on bowel symptoms and health‐related quality of life in irritable bowel syndrome (IBS)

Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring

Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration

Genetic risk factors for perception of symptoms in GERD: an observational cohort study

Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials

The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome

A meta‐analysis of immunogenetic Case–Control Association Studies in irritable bowel syndrome

Genetic variation in the beta‐2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health‐related quality of life

Cameron lesions in patients with hiatal hernias: prevalence, presentation, and treatment outcome

Colonoscopy Following COVID-19 Delays in Procedures: Risk Stratification for Procedures Is Critical

Tegaserod: What’s Old Is New Again

Changes in symptom reflux association using dynamic pH thresholds during ambulatory pH monitoring: an observational cross‐sectional study

Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice

Nontransplantation of Livers from Deceased Donors Who Are Able to Donate Another Solid Organ: How Often and Why It Happens

miRNA-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in Irritable Bowel Syndrome (IBS)

Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective study

Irritable Bowel Syndrome: Modern Concepts and Management Options

Suchergebnisse filtern